Single-port transoral robotic surgery for a rare tonsil mass
- PMID: 37090905
- PMCID: PMC10115462
- DOI: 10.1093/jscr/rjad197
Single-port transoral robotic surgery for a rare tonsil mass
Abstract
Squamous cell carcinoma predominates as the most common malignant lesion of the oropharynx with human papilloma virus-associated disease now predominant over tobacco-related oropharynx cancer. Other rare malignant pathologies can manifest as visible neoplasms in these anatomic sites with varying degrees of symptoms such as dysphagia, odynophagia, otalgia, aspiration, hemorrhage, weight loss and dyspnea. We present a case of a rarely encountered primary oropharyngeal sarcoma managed by single-port transoral robotic resection and a selective cervical lymph node dissection followed by adjuvant radiotherapy.
Published by Oxford University Press and JSCR Publishing Ltd. © The Author(s) 2023.
Conflict of interest statement
None declared.
Figures
Similar articles
-
Transoral radical tonsillectomy and retropharyngeal lymph node dissection with a flexible next generation robotic surgical system.Head Neck. 2018 Jun;40(6):1296-1298. doi: 10.1002/hed.25118. Epub 2018 Feb 23. Head Neck. 2018. PMID: 29473252
-
A flexible, single-arm robotic surgical system for transoral resection of the tonsil and lateral pharyngeal wall: Next-generation robotic head and neck surgery.Laryngoscope. 2016 Apr;126(4):864-9. doi: 10.1002/lary.25724. Epub 2015 Oct 28. Laryngoscope. 2016. PMID: 26509920
-
Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes.Head Neck. 2017 Oct;39(10):1969-1975. doi: 10.1002/hed.24786. Epub 2017 Jul 31. Head Neck. 2017. PMID: 28758272
-
Transoral laser resection with staged discontinuous neck dissection for oral cavity and oropharynx squamous cell carcinoma.Laryngoscope. 1995 Jan;105(1):53-60. doi: 10.1288/00005537-199501000-00013. Laryngoscope. 1995. PMID: 7837914 Review.
-
De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.Cochrane Database Syst Rev. 2018 Dec 14;12(12):CD012939. doi: 10.1002/14651858.CD012939.pub2. Cochrane Database Syst Rev. 2018. PMID: 30550641 Free PMC article.
References
-
- Mahal BA, Catalano PJ, Haddad RI, et al. Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States. Cancer Epidemiol Biomarkers Prev 2019;28:1660–7. - PubMed
-
- Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407–20. - PubMed
-
- Old M. Reduction of severe oropharyngeal hemorrhage following transoral robotic surgery. Oral Oncol 2017;72:190–1. - PubMed
-
- Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, et al. Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311). J Clin Oncol Off J Am Soc Clin Oncol 2022;40:138–49. - PMC - PubMed
-
- Dukers NHTM, Renwick N, Prins M, Geskus RB, Schulz TF, Weverling GJ, et al. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexula men. Am J Epidemiol 2000;151:213–24. - PubMed
Publication types
LinkOut - more resources
Full Text Sources